,address1,address2,city,state,zip,country,phone,website,industry,industryDisp,sector,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,profitMargins,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,lastSplitFactor,lastSplitDate,52WeekChange,SandP52WeekChange,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,uuid,messageBoardId,gmtOffSetMilliseconds,currentPrice,recommendationKey,totalCash,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,returnOnAssets,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,275 Grove Street,Suite 2-400,Auburndale,MA,02466,United States,617-419-3289,https://www.alseres.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"Alseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is based in Auburndale, Massachusetts.",3,"{'maxAge': 1, 'name': 'Mr. Peter G. Savas', 'age': 74, 'title': 'Exec. Chairman', 'yearBorn': 1948, 'fiscalYear': 2007, 'exercisedValue': 0, 'unexercisedValue': 0}",1388448000,86400,4,0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.0,0.155947,38,38,0,0,0,0.0,0.0,0,0,398255,0.01,0.01,0.8406793,0.01,0.01,0.0,0.0,USD,-1.6394099,6127,0,0,1238457600,1241049600,0.0001,0.0,0.0,39825500,1388448000,1419984000,1404086400,-776636,-0.02,1:5000,1419984000,0.0,0.14113986,PNK,EQUITY,ALSE,ALSE,ALSERES PHARMACEUTICALS INC,"Alseres Pharmaceuticals, Inc.",788106600,America/New_York,EDT,d99ebcfd-0319-3153-b730-4960a989ec65,finmb_25722,-14400000,0.01,none,186954,-843188,8915590,0.103,0.121,473730,-2.4706,450043,-2427915,-1344280,0.0,0.94611,-1.77989,-1.78114,USD,
1,275 Grove Street,Suite 2-400,Auburndale,MA,02466,United States,617-419-3289,https://www.alseres.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"Alseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is based in Auburndale, Massachusetts.",3,"{'maxAge': 1, 'name': 'Mr. Sam  Martin', 'title': 'Director of Fin. & Corp. Compliance', 'exercisedValue': 0, 'unexercisedValue': 0}",1388448000,86400,4,0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.0,0.155947,38,38,0,0,0,0.0,0.0,0,0,398255,0.01,0.01,0.8406793,0.01,0.01,0.0,0.0,USD,-1.6394099,6127,0,0,1238457600,1241049600,0.0001,0.0,0.0,39825500,1388448000,1419984000,1404086400,-776636,-0.02,1:5000,1419984000,0.0,0.14113986,PNK,EQUITY,ALSE,ALSE,ALSERES PHARMACEUTICALS INC,"Alseres Pharmaceuticals, Inc.",788106600,America/New_York,EDT,d99ebcfd-0319-3153-b730-4960a989ec65,finmb_25722,-14400000,0.01,none,186954,-843188,8915590,0.103,0.121,473730,-2.4706,450043,-2427915,-1344280,0.0,0.94611,-1.77989,-1.78114,USD,
